Quick Answer
Fulgent Genetics, Inc. reported Common Stock Shares Outstanding of 31.08 million shares for the year ending 2025.
- Fulgent Genetics, Inc. showed an increase of +0.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Fulgent Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Fulgent Genetics, Inc.'s Common Stock Shares Outstanding has grown by 75.8%.
- Historical annual values: Fiscal year 2025: 31.08 million shares | Fiscal year 2024: 30.84 million shares | Fiscal year 2023: 29.65 million shares | Fiscal year 2022: 29.44 million shares | Fiscal year 2021: 30.16 million shares | Fiscal year 2020: 28.18 million shares | Fiscal year 2019: 21.48 million shares | Fiscal year 2018: 18.17 million shares | Fiscal year 2017: 17.85 million shares | Fiscal year 2016: 17.68 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: